Kuickresearch::Industry News

1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10 | 11 | 12 | 13 | 14 | 15 | 16 | 17 | 18 | 19 | 20 | 21 | 22 | 23 | 24 | 25 | 26 | 27 | 28 | 29 | 30 | 31 | 32 | 33 | 34 | 35 | 36 | 37 | 38 | 39 | 40 | 41 | 42 | 43 | 44 | 45 | 46 | 47 | 48 | 49 | 50 | 51 | 52 | 53 | 54 | 55 |

TRIM37 Overexpression and PLK4 Inhibitor to Come up as Novel Breast Cancer Treatment Regimen

Release Date: 20 November 2020

A group of researchers at Johns Hopkins University School of Medicine and the University of Oxford have developed a potential mechanism of action of stopping the cancer cells found in breast cancer by targeting an important key mechanism...

Read More


MIT Researchers to Uncover More Potent Version of Kl-Arv-03 against Prostate Cancer Cell Lines

Release Date: 20 November 2020

Prostate cancer is among the most diagnosed cancer type in men, which is majorly driven by male sex hormone. A group of researchers have inclined their focus towards developing a small molecule that could target an important protein that...

Read More


Multi-Valent Targeting by CAR-T Cell Therapy Emerging as Novel Multiple Myeloma Treatment

Release Date: 19 November 2020

Global therapeutics industry has observed tons of successful technologies and techniques in the past few years and similar is in the case for treating relapsed multiple myeloma. The recent development in the mechanism of action of treating relapsed multiple myeloma has resulted in an increase ove...

Read More


Autism Spectrum Disorder Treatment Supported by Novel Stem Cell Therapy and Educational Intervention

Release Date: 19 November 2020

A novel clinical trial is focused towards combining the strategies of stem cell therapy as well as educational intervention in the treatment of the patients suffering from autism spectrum disorder (ASD). The respective clinical research ...

Read More


Stem Cell Combination Therapy with Enzyme Inhibitors Leading towards Declined Rate of Heart Attacks

Release Date: 19 November 2020

For the treatment of damaged heart tissues, blocking an enzyme related with inflammation is believed to be useful as it will lead to the stem cells to repair it. The respective enzyme that is believed to be effective in case of treating the damaged heart tissues is s...

Read More


Induced Trophoblast Stem Cells to Treat Pregnant Ladies with Placental Problems

Release Date: 19 November 2020

Recently, a collaboration has taken place between Duke-NUS Medical School and Monash University researchers for the overall development of the very first stem cell therapy against the placental complications that are observed by the preg...

Read More


Stromal Cell Therapy to get Recognized as Emerging anthracycline-Induced Cardiomyopathy Treatment

Release Date: 19 November 2020

Patients suffering from anthracycline-induced cardiomyopathy are estimated to receive benefits from transendocardial administration of allogenic bone marrow-derived mesenchymal stromal cells. As per the clinical research activity with 31...

Read More


CAR-T Cell Therapy and Oncolytic Virus Therapy to be Safe and Effective in the Solid Cancer Patients

Release Date: 19 November 2020

A group of researchers are inclined towards combining two different immunotherapies i.e. oncolytic virus and chimeric antigen receptor (CAR) T cell therapy for the eradication of the solid cancer cells from the body of the patients. The ...

Read More


Myocardial Infraction Clinical Trial Study to Observe Obstacles in Future Years

Release Date: 19 November 2020

Researchers are inclined towards evaluating autologous cell-based therapy for the patients that have acute MI. It has been concluded by the researchers that the therapy could decrease HF hospitalization. But inadequate recruitment for th...

Read More


ICANS to have no Impact on the Overall Survival in Lymphoma Patients

Release Date: 19 November 2020

Researchers have witnessed that the development of immune effector cell-associated neurotoxicity syndrome (ICANS) was not negatively affecting the survival outcomes among relapsed or refractory large B-cell lymphoma patients who are given axicabtagene ciloleucel.&nbs...

Read More


Gene T cell Therapy to Emerge as a Novel Treatment Regimen for Epithelial Cancers

Release Date: 19 November 2020

A novel study is focused towards determining the clinical activity as well as safety of E7 TCR-T cells in the treatment of the patients suffering from refractory metastatic HPV- 16+ cancers. The researchers involved in the respective stu...

Read More


Combinational Therapy to Overcome High Mortality Rate in HR+, HER2- Breast Cancer

Release Date: 19 November 2020

There was 25% reduction in the risk of developing recurrence of invasive disease when CDK4/6 inhibitor, abemaciclib was introduced in the patients in combination with some standard endocrine therapy suffering from hormone receptor-positi...

Read More


Trispecific Cancer Antibody Therapy Market Insight

Release Date: 18 November 2020

Global Tri-specific cancer antibody therapy market in the upcoming time period is estimated to deliver widespread opportunities and trends for the researchers and the patients as it is considered as a model therapy capable of responding to every cancer type diagnosed...

Read More


Celyad Biosciences to Improve CAR-T Cell Therapy by the Introduction of shRNA

Release Date: 18 November 2020

Celyad Bioscience is a clinical stage biotechnology company which is focused towards the overall development of the CAR-T cell therapy for the cancer patients. The approach used by the researchers involves antigen–receptor binding....

Read More


Emerging Computational Model to Accelerate Therapeutic Applications

Release Date: 18 November 2020

Now-a-days, cellular therapy is considered as a very promising and powerful treatment strategy against different types of disease but one of the major challenges that is found in the cellular therapy is keeping the cells alive in the lab conditions. But a group of re...

Read More


1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10 | 11 | 12 | 13 | 14 | 15 | 16 | 17 | 18 | 19 | 20 | 21 | 22 | 23 | 24 | 25 | 26 | 27 | 28 | 29 | 30 | 31 | 32 | 33 | 34 | 35 | 36 | 37 | 38 | 39 | 40 | 41 | 42 | 43 | 44 | 45 | 46 | 47 | 48 | 49 | 50 | 51 | 52 | 53 | 54 | 55 |

Need custom market research solution? We can help you with that too.